These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31674042)
41. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial). Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368 [TBL] [Abstract][Full Text] [Related]
42. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening. Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670 [TBL] [Abstract][Full Text] [Related]
43. Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme. Kearns B; Whyte S; Chilcott J; Patnick J Br J Cancer; 2014 Oct; 111(9):1734-41. PubMed ID: 25180767 [TBL] [Abstract][Full Text] [Related]
45. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Brenner H; Tao S Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981 [TBL] [Abstract][Full Text] [Related]
46. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542 [TBL] [Abstract][Full Text] [Related]
47. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542 [TBL] [Abstract][Full Text] [Related]
48. Post-colonoscopy colorectal cancer: A population-based cohort study of fecal occult blood test-positive colonoscopies. Denis B; Bertolaso A; Gendre I; Perrin P; Hammas K Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102285. PubMed ID: 38246488 [TBL] [Abstract][Full Text] [Related]
49. Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening. Carrera A; McClements PL; Watling C; Libby G; Weller D; Brewster DH; Carey FA; Fraser CG; Steele RJ Colorectal Dis; 2012 Aug; 14(8):943-6. PubMed ID: 21981347 [TBL] [Abstract][Full Text] [Related]
50. Fecal occult blood testing for iron deficiency: a reappraisal. Harewood GC; Ahlquist DA Dig Dis; 2000; 18(2):75-82. PubMed ID: 11060470 [TBL] [Abstract][Full Text] [Related]
51. Non-invasive screening for colorectal cancer in Asia. Chiu HM; Chang LC; Hsu WF; Chou CK; Wu MS Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):953-65. PubMed ID: 26651256 [TBL] [Abstract][Full Text] [Related]
52. [Usefulness of combining a immunological fecal occult blood test (latex method) with a chemical test (guaiac method)]. Hamajima E; Asai T; Okumura S; Yamaguchi H; Katou T; Yamamoto Y; Kinoshita O Gan No Rinsho; 1990 Jan; 36(1):71-4. PubMed ID: 2299793 [TBL] [Abstract][Full Text] [Related]
53. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919 [TBL] [Abstract][Full Text] [Related]
54. [Fecal occult blood--does a hemoglobin-specific tests improve the diagnosis of relevant colonic neoplasms?]. Gysi B; Lang C; Affolter H Schweiz Med Wochenschr; 1991 Jun; 121(26):988-90. PubMed ID: 1862316 [TBL] [Abstract][Full Text] [Related]
55. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive. Gordon JC; Steele RJ; Fraser CG Ann Clin Biochem; 2004 Nov; 41(Pt 6):488-90. PubMed ID: 15588441 [TBL] [Abstract][Full Text] [Related]
56. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology. Stelling HP; Maimon HN; Smith RA; Haddy RI; Markert RJ Arch Intern Med; 1990 May; 150(5):1001-5. PubMed ID: 2331181 [TBL] [Abstract][Full Text] [Related]
57. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Zappa M; Castiglione G; Paci E; Grazzini G; Rubeca T; Turco P; Crocetti E; Ciatto S Int J Cancer; 2001 Apr; 92(1):151-4. PubMed ID: 11279619 [TBL] [Abstract][Full Text] [Related]
58. A comparative study of three fecal occult blood tests in upper gastrointestinal bleeding. Chiang CH; Jeng JE; Wang WM; Jheng BH; Hsu WT; Chen BH Kaohsiung J Med Sci; 2006 May; 22(5):223-8. PubMed ID: 16793557 [TBL] [Abstract][Full Text] [Related]
59. Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening. Launois R; Le Moine JG; Uzzan B; Fiestas Navarrete LI; Benamouzig R Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):978-89. PubMed ID: 25072382 [TBL] [Abstract][Full Text] [Related]
60. [Causes of error in the determination of occult fecal blood]. LODI A; TUCCI G Arch Ital Mal Appar Dig; 1959; 26():481-3. PubMed ID: 14417818 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]